Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132135) titled 'Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients with Obesity Complicated by Chronic Kidney Disease with Albuminuria' on Sept. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University People's Hospital
Condition:
Adult patients with obesity and chronic kidney disease (CKD) with albuminuria and without diabetes
Intervention:
Finerenone combined with semaglutide injection:Finerenone combined with semaglutide injection for intervention
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrol...